Drugs in sport

British Journal of Pharmacology

Volumn 154, Issue 3, 2008, Pages 493-495

  McGrath, J C ^a,c   Cowan, D A ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

adrenoceptors; blockers antagonists; Anabolic agents; Doping; Erythropoetin; Gene doping; Growth factors; Insulin; Sport; Stimulants

Indexed keywords

ANABOLIC AGENT; AROMATASE INHIBITOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL STIMULANT AGENT; CHORIONIC GONADOTROPIN; CLENBUTEROL; CORTICOTROPIN; EPITESTOSTERONE; GROWTH FACTOR; HUMAN GROWTH HORMONE; ILLICIT DRUG; INSULIN; LUTEINIZING HORMONE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROBENECID; RECOMBINANT ERYTHROPOIETIN; SOMATOMEDIN C; TESTOSTERONE;

DOPING; DRUG MISUSE; LEAN BODY WEIGHT; NOTE; OXYGEN TENSION; PRIORITY JOURNAL; PUBLICATION; SPORT;

ATHLETIC PERFORMANCE; DOPING IN SPORTS; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; MALE; SPORTS; SUBSTANCE ABUSE DETECTION;

EID: 44349110660     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.171     Document Type: Note

References (12)

1. Davis E, Loiacono R, Summers RJ (2008). The rush to adrenaline - drugs in sport acting on the β-adrenergic system. Br J Pharmacol 154: 584-597 (this issue).
2. Docherty JR (2008). Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). Br J Pharmacol 154: 606-622 (this issue).
3. Elliott S (2008). Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. Br J Pharmacol 154: 529-541 (this issue).
4. Handelsman DJ (2008). Indirect androgen doping by oestrogen blockade in sports. Br J Pharmacol 154: 598-605. (this issue)
5. Holt RIG, Sönksen PH (2008). Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol 154: 542-556 (this issue).
6. Kadi F (2008). Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br J Pharmacol 154: 522-528 (this issue).
7. Kicman AT (2008). Pharmacology of Anabolic Steroids. Br J Pharmacol 154: 502-521 (this issue).
8. Spedding M, Spedding C (2008). Drugs in sport - an athlete's perspective. Br J Pharmacol 154: 496-501 (this issue).
9. Stenman U-H, Hotakainen K, Alfthan H (2008). Gonadotropins in doping: pharmacological basis and detection of illicit use. Br J Pharmacol 154: 569-583 (this issue).
10. Velloso CP (2008). Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 154: 557-568 (this issue).
11. Wells DJ (2008). Gene Doping: the hype and the reality. Br J Pharmacol 154: 623-631 (this issue).
12. World Anti-Doping Agency (2008). The World Anti-Doping Code. The 2008 Prohibited List International Standard. http://www.wada-ama.org/rtecontent/ document/2008_List_En.pdf.